News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

14,699 Results

Type

Article (2622)
Company Profile (5)
Press Release (12072)

Section

Business (5456)
Career Advice (73)
Deals (903)
Drug Delivery (7)
Drug Development (2467)
Employer Resources (6)
FDA (416)
Job Trends (705)
News (9112)
Policy (1039)

Tag

Date

Last 7 days (16)
Last 30 days (48)
Last 365 days (814)
2024 (811)
2023 (823)
2022 (1670)
2021 (1439)
2020 (1235)
2019 (846)
2018 (678)
2017 (874)
2016 (792)
2015 (967)
2014 (605)
2013 (526)
2012 (548)
2011 (541)
2010 (507)

Location

Africa (58)
Asia (804)
Australia (98)
California (119)
Canada (15)
China (21)
Europe (4625)
Florida (8)
Maryland (7)
Massachusetts (34)
New Jersey (14)
New York (51)
North Carolina (3)
Northern California (87)
Pennsylvania (14)
South America (63)
Southern California (27)
Texas (4)
Utah (3)

Filters

Type

Article (2622)
Company Profile (5)
Press Release (12072)

Section

Business (5456)
Career Advice (73)
Deals (903)
Drug Delivery (7)
Drug Development (2467)
Employer Resources (6)
FDA (416)
Job Trends (705)
News (9112)
Policy (1039)

Tag

Date

Last 7 days (16)
Last 30 days (48)
Last 365 days (814)
2024 (811)
2023 (823)
2022 (1670)
2021 (1439)
2020 (1235)
2019 (846)
2018 (678)
2017 (874)
2016 (792)
2015 (967)
2014 (605)
2013 (526)
2012 (548)
2011 (541)
2010 (507)

Location

Africa (58)
Asia (804)
Australia (98)
California (119)
Canada (15)
China (21)
Europe (4625)
Florida (8)
Maryland (7)
Massachusetts (34)
New Jersey (14)
New York (51)
North Carolina (3)
Northern California (87)
Pennsylvania (14)
South America (63)
Southern California (27)
Texas (4)
Utah (3)

14,699 Results for "sanofi pasteur".

Sort By

Podcast

Trodelvy’s Bladder Cancer Withdrawal, Sage Therapeutics Layoffs, Sanofi’s Radiopharma Investment, More

Yet another therapy with FDA accelerated approval suffers a setback; Sage’s tough year continues; Sanofi drops $326 million in radiopharma while selling its consumer health unit; Novo Nordisk’s positive Rybelsus results in cardiovascular disease; and more.

October 23, 2024
·
1 min read
·
Heather McKenzie
Radiopharmaceuticals

Sanofi Inks $326M Radiopharma Deal With Orano

Thursday’s agreement with Orano Med is the second in as many months. Sanofi in September made its first foray into the radioligand space with a $110 million licensing deal with Orano Med and Texas biotech RadioMedix.

October 17, 2024
·
2 min read
·
Tristan Manalac
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology

Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology

May 29, 2024
·
3 min read
Healthcare

As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals

Sanofi looks to follow a deep history of Big Pharma offloading their consumer healthcare businesses.

October 16, 2024
·
6 min read
·
Annalee Armstrong
Deals

Sanofi Seals Deal With Private Equity Firm for 50% Stake in Consumer Healthcare Unit

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French government taking a stake as well to ensure the business remains in the county.

October 21, 2024
·
2 min read
·
Annalee Armstrong
FDA

Sanofi and Regeneron’s Dupixent Snags First Biologic Approval in COPD

Already approved in six indications, Sanofi and Regeneron can now add chronic obstructive pulmonary disease to the list for their blockbuster injection.

September 27, 2024
·
2 min read
·
Kate Goodwin
Earnings

Sanofi Beats Q3 Forecasts Fueled by 381% Growth in Beyfortus Sales

The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, bringing in almost $700 million in the third quarter. Leerink Partners analyst David Risinger in a Friday note to investors said Sanofi expects Q4 Beyfortus sales similar to Q3.

October 25, 2024
·
3 min read
·
Tristan Manalac
Multiple sclerosis

Roche Touts Phase II MS Data on Heels of Sanofi’s Late-Stage Stumbles

Days after Sanofi reported back-to-back failures for its BTK inhibitor, Roche’s fenebrutinib on Wednesday scored a mid-stage win in relapsing multiple sclerosis, demonstrating near-total elimination of disease activity.

September 4, 2024
·
2 min read
·
Tristan Manalac
Approvals

Sanofi Secures First-Line Nod for Sarclisa in Multiple Myeloma, Tees Up Competition With J&J

With Friday’s approval, Sanofi’s anti-CD38 antibody Sarclisa will go head-to-head with the first such therapy for multiple myeloma, Johnson & Johnson’s Darzalex, which raked in nearly $10 billion last year.

September 23, 2024
·
2 min read
·
Tristan Manalac
Rare diseases

Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal

Under the deal announced Friday, the Italian pharma will make an upfront payment of $825 million to Sanofi for global rights to a biologic for the treatment of cold agglutinin disease, with milestone payments of up to $250 million.

October 4, 2024
·
2 min read
·
Tristan Manalac

1 of 1,470

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin